Now that Novo Nordisk is the world’s weight-loss juggernaut, will it have to betray its first patients—type 1 diabetics?

A dozen GLP-1 receptor agonists and coagonists demonstrated effectiveness for weight loss in adults with obesity and without ...

Obesity medications could help heavy drinkers cut down on the booze as well as helping them lose weight, new research has ...

Alcohol intake dropped from 23 units to eight per week - roughly the equivalent to going from 12 pints a week to only four.

Heavy drinkers who were ­taking weight-loss jabs in a Dublin clinic significantly reduced their ­alcohol intake down from 12 ...

Shares of Biocon surged as much as 5 per cent during the trading session on Monday after the USFDA cleared Malaysia unit to ...

The growing emphasis on advanced liver fibrosis treatments highlights a paradigm shift in addressing chronic liver diseases, ...

This study links Ffar4, gut microbiota, and sugar preference, highlighting potential strategies for managing diabetes and ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Discover key insights from dietitians on gut health, weight loss medications and the influence of social media on our eating ...

For adults with overweight or obesity without diabetes, glucagon-like peptide-1 receptor agonists are efficacious for weight loss.